SFX by Ex Libris Inc.

Title:	Molecular challenges in modern chemometrics
Source:	Analytica Chimica Acta [0003-2670] Wehrens, R yr:1999

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Yadav, A. "Co-Crystals: A Novel Approach to Modify Physicochemical Properties of Active Pharmaceutical Ingredients." Indian journal of pharmaceutical sciences 71.4 (2009): 359-370.
description	2.	Blagden, N. "Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates." Advanced Drug Delivery Reviews 59.7 (2007): 617-630.
description	3.	HICKEY, Magali B. "Performance comparison of a co-crystal of carbamazepine with marketed product." European journal of pharmaceutics and biopharmaceutics 67.1 (2007): 112-119.
description	4.	Steed, J. "The role of co-crystals in pharmaceutical design." Trends in pharmacological sciences 34.3 (2013): 185-193.
description	5.	Childs, Scott L. "Crystal Engineering Approach To Forming Cocrystals of Amine Hydrochlorides with Organic Acids. Molecular Complexes of Fluoxetine Hydrochloride with Benzoic, Succinic, and Fumaric Acids." Journal of the American Chemical Society 126.41 (2004): 13335-13335.
description	6.	Porter III, William W. "Polymorphism in Carbamazepine Cocrystals." Crystal growth & design 8.1 (2008): 14-16.
description	7.	Rodriguez-Hornedo, N. "Solubility Advantage of Pharmaceutical Cocrystals." Crystal growth & design 9.5 (2009): 2252-2264.
description	8.	McNamara, Daniel P. "Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API." Pharmaceutical Research 23.8 (2006): 1888-97.
description	9.	Allen, Peter T A H. "Persistent hydrogen bonding in polymorphic crystal structures." Acta crystallographica. Section B, Structural science 65.1 (2009): 68-85.
description	10.	Remenar, Julius F. "Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids." Journal of the American Chemical Society 125.28 (2003): 8456-8457.
description	11.	Newman, N. "Pharmaceutical Cocrystals and Their Physicochemical Properties." Crystal growth & design 9.6 (2009): 2950-2967.
description	12.	Rodriguez-Spong, B. "General principles of pharmaceutical solid polymorphism: a supramolecular perspective." Advanced Drug Delivery Reviews 56.3 (2004): 241-274.
description	13.	Morris, K. R. "Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes." Advanced Drug Delivery Reviews 48.1 (2001): 91-114.
description	14.	Basavoju, S. "Indomethacin-Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization." Pharmaceutical Research 25.3 (2008): 530-541.
description	15.	Shah, Shailesh A. "Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies." Pharmaceutical development and technology 18.2 (2013): 443-53.
description	16.	Morissette, Sherry L. "High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids." Advanced Drug Delivery Reviews 56.3 (2004): 275-300.
description	17.	Braga, D. "Combining piracetam and lithium salts: ionic co-crystals and co-drugs?" Chemical communications (London. 1996) 48.66 (2012): 8219-8221.
description	18.	Jeffrey, George A. "Hydrogen-Bonding: An update." Crystallography reviews 9.2 (2003): 135-176.
description	19.	Parkin, A. "What is a co-crystal - and does it matter?" Zeitschrift für Kristallographie, Kristallgeometrie, Kristallphysik, Kristallchemie 223.6 (2008): 430-430.
description	20.	DESIRAJU, G.R. R. "SUPRAMOLECULAR SYNTHONS IN CRYSTAL ENGINEERING - A NEW ORGANIC-SYNTHESIS." Angewandte Chemie. International edition in English 34.21 (1995): 2311-2327.